ONO 3051
Latest Information Update: 03 Feb 1997
At a glance
- Originator Ono Pharmaceutical
- Class Antiemetics; Antimigraines; Anxiolytics
- Mechanism of Action Serotonin 3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 03 Feb 1997 No-Development-Reported for Emesis in Japan (Unknown route)